Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
1 other identifier
observational
500
1 country
1
Brief Summary
In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and future possible influence on disease management for patients affected by those diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 15, 2019
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedOctober 10, 2023
October 1, 2023
8.5 years
January 15, 2019
October 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Morphological changes using Swept Source Optical Coherence Tomography
Morphological changes in retinal diseases provided by Swept Source Optical
through study completion, an average of 1 year
Interventions
We will use a commercially available SS-OCT system (Plex Elite 9000; Carl Zeiss Meditec).
Eligibility Criteria
The participants will be selected by the Department of Ophthalmology at Kepler University Clinic Linz. All patients of the department scheduled for an outgoing appointment with regular examination in the time period of the study can be included in the study. Patients are being examined in the outgoing clinics with standard examinations. Additionally an image using the Zeiss Plex Elite 9000 Swept Source OCT is being performed. Patients of interest for this pilot study are patients with retinal, choroidal, vascular or glaucomatous changes.
You may qualify if:
- Age between 5 and 110 years
- Ability to follow instructions during imaging procedure
- Written Informed consent
You may not qualify if:
- Dementia
- Inability to follow instructions during imaging procedure
- Patients who do not give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Linz, Upper Austria, 4020, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Bolz, Prof. Dr.
Department for Ophthalmology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Ophthalmology and Optometry
Study Record Dates
First Submitted
January 15, 2019
First Posted
October 10, 2023
Study Start
June 1, 2017
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
October 10, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share